Gemtesa 75 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Z51
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,104
Award facts
- Contract value 100% obligated
- $12,103.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,103.78 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations.
This delivery order is one of numerous pharmaceutical procurement actions under the DLA Troop Support Medical IDC, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, specialty drugs, and medical supplies to military healthcare programs and federal medical institutions worldwide. AmerisourceBergen's significant role in federal pharmaceutical distribution demonstrates the company's capability to meet government procurement requirements through open competition, with contract awards spanning multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5Z51?
SPE2DR26F5Z51 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F5Z51 worth?
The government has obligated $12,104 on SPE2DR26F5Z51.
Is contract SPE2DR26F5Z51 an order under another contract?
Yes. SPE2DR26F5Z51 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Z51 competed?
The extent of competition for SPE2DR26F5Z51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award